Two Sigma Advisers
BIOC

Two Sigma Advisers’s Biocept, Inc. BIOC Stock Holding History

Two Sigma Advisers’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-467
Closed -$13K – 2762
2022
Q3 		$13K Sell
467
-220
-32% -$6.51K ﹤0.01% 2469
2022
Q2 		$19K Sell
687
-413
-38% -$18.8K ﹤0.01% 2555
2022
Q1 		$77K Sell
1,100
-183
-14% -$14.4K ﹤0.01% 2540
2021
Q4 		$139K Buy
+1,283
New +$148K ﹤0.01% 2371

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Two Sigma Advisers's BIOC Position: Q4 2022 in Review

Two Sigma Advisers sold out of Biocept, Inc. (BIOC) in Q4 2022, closing a stake of 467 shares — an estimated $13K sold.

Two Sigma Advisers first reported a position in BIOC in Q4 2021 and held it in 4 quarters. The position peaked at $139K in Q4 2021. 25 funds tracked by Wall St. Rank hold BIOC as of Q4 2022.

  • Two Sigma Advisers reported no remaining Biocept, Inc. position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 467 Biocept, Inc. shares in Q4 2022, an estimated $13K.
  • Two Sigma Advisers first reported a position in Biocept, Inc. in Q4 2021 and held it in 4 quarters.
  • Two Sigma Advisers's Biocept, Inc. position peaked at $139K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.